Abstract
Percutaneous left atrial appendage closure (LAAC) has been reported many therapeutic effects with regard to its safety and efficacy, and the number of patients with non-valvular atrial fibrillation undergoing LAAC is increasing worldwide. Although it is a highly safe procedure, further improvements are expected and preoperative planning is extremely important. For this purpose, transesophageal echocardiography has been mainly performed so far, however, nowadays, it is recommended to determine a more optimal treatment strategy combined with computed tomography. Preoperative CT predicts not only the risk of the intervention based on anatomical features of the left atrial appendage (LAA) but also the device type and size, sheath type, optimal location for septal puncture and pre-procedurally clarifies the left atrium and LAA dimensions. Furthermore, postoperative CT can evaluate device-related thrombus and peri-device leak, making it possible to observe the postoperative course using less invasive methods. This study reviews the practical utility of CT in pre- and post-LAAC.
Similar content being viewed by others
Abbreviations
- AF:
-
Atrial fibrillation
- ECG:
-
Electrocardiogram
- MSCT:
-
Multi-slice computed tomography
- DOAC:
-
Direct oral anticoagulant
- DRT:
-
Device-related thrombus
- HU:
-
Hounsfield unit
- LA:
-
Left atrium
- LAA:
-
Left atrial appendage
- LAAC:
-
Left atrial appendage closure
- LCx:
-
Left circumflex coronary artery
- MPR:
-
Multiplanar reconstruction
- OAC:
-
Oral anticoagulant
- PDL:
-
Peri-device leak
- TEE:
-
Transesophageal echocardiography
- VR:
-
Volume rendering
References
Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36:1115–9.
Lip GY, Frison L, Halperin JL, Lane DA. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke. 2010;41:2731–8.
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.
Senoo K, Lane DA, Lip GY. Oral anticoagulants for stroke prevention in atrial fibrillation. Curr Probl Cardiol. 2014;39:319–44.
Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349:1019–26.
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.
Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093–104.
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.
Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988–98.
Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.
Holmes DR Jr, Doshi SK, Kar S, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65:2614–23.
Osmancik P, Herman D, Neuzil P, et al. 4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2022;79:1–14.
Kar S, Doshi SK, Sadhu A, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial. Circulation. 2021;143:1754–62.
Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial. Circulation. 2021;144:1543–52.
Galea R, De-Marco F, Meneveau N, et al. Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial. Circulation. 2021. https://doi.org/10.1161/CIRCULATIONAHA.121.057859.
So CY, Kang G, Villablanca PA, et al. Additive value of preprocedural computed tomography planning versus stand-alone transesophageal echocardiogram guidance to left atrial appendage occlusion: comparison of real-world practice. J Am Heart Assoc. 2021;10:e020615.
Staab W, Goth S, Sohns C, et al. Comparison of end-diastolic versus end-systolic cardiac-computed tomography reconstruction interval in patient’s prior to pulmonary vein isolation. Springerplus. 2014;3:218.
Patel AR, Fatemi O, Norton PT, et al. Cardiac cycle-dependent left atrial dynamics: implications for catheter ablation of atrial fibrillation. Heart Rhythm. 2008;5:787–93.
Korsholm K, Berti S, Iriart X, et al. Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion. JACC Cardiovasc Interv. 2020;13:277–92.
Budoff MJ, Shittu A, Hacioglu Y, et al. Comparison of transesophageal echocardiography versus computed tomography for detection of left atrial appendage filling defect (thrombus). Am J Cardiol. 2014;113:173–7.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–78.
Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–8.
Naksuk N, Padmanabhan D, Yogeswaran V, Asirvatham SJ. Left atrial appendage: embryology, anatomy, physiology, arrhythmia and therapeutic intervention. JACC Clin Electrophysiol. 2016;2:403–12.
Korhonen M, Muuronen A, Arponen O, et al. Left atrial appendage morphology in patients with suspected cardiogenic stroke without known atrial fibrillation. PLoS ONE. 2015;10:e0118822.
Korhonen M, Parkkonen J, Hedman M, et al. Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation. PLoS ONE. 2017;12:e0173703.
Yu CM, Khattab AA, Bertog SC, et al. Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation. Nat Rev Cardiol. 2013;10:707–22.
Hosoda N, Asami M, Tanaka J, Usui T, Tanabe K. Usefulness of preprocedural dedicated computed tomography for complex case in percutaneous left atrial appendage closure. Cardiovasc Interv Ther. 2021;36:559–61.
Rajwani A, Nelson AJ, Shirazi MG, et al. CT sizing for left atrial appendage closure is associated with favourable outcomes for procedural safety. Eur Heart J Cardiovasc Imaging. 2017;18:1361–8.
Wang DD, Eng M, Kupsky D, et al. Application of 3-Dimensional computed tomographic image guidance to WATCHMAN implantation and impact on early operator learning curve: single-center experience. JACC Cardiovasc Interv. 2016;9:2329–40.
Wang K, Duan CY, Wu J, et al. Predictive value of neutrophil gelatinase-associated lipocalin for contrast-induced acute kidney injury after cardiac catheterization: a meta-analysis. Can J Cardiol. 2016;32(1033):e19-29.
Hołda MK, Koziej M, Wszołek K, et al. Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents. Int J Cardiol. 2017;244:163–8.
Abbara S, Mundo-Sagardia JA, Hoffmann U, Cury RC. Cardiac CT assessment of left atrial accessory appendages and diverticula. AJR Am J Roentgenol. 2009;193:807–12.
Troupis J, Crossett M, Scneider-Kolsky M, Nandurkar D. Presence of accessory left atrial appendage/diverticula in a population with atrial fibrillation compared with those in sinus rhythm: a retrospective review. Int J Cardiovasc Imaging. 2012;28:375–80.
Wan Y, He Z, Zhang L, et al. The anatomical study of left atrium diverticulum by multi-detector row CT. Surg Radiol Anat. 2009;31:191–8.
Şeker M. The characteristics of left atrial diverticula in normal sinüs rhythm patients. Surg Radiol Anat. 2020;42:377–84.
Sanfilippo AJ, Abascal VM, Sheehan M, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990;82:792–7.
Barbier P, Alioto G, Guazzi MD. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1994;24:165–70.
Dittrich HC, Pearce LA, Asinger RW, et al. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J. 1999;137:494–9.
Nakamura K, Funabashi N, Uehara M, et al. Left atrial wall thickness in paroxysmal atrial fibrillation by multislice-CT is initial marker of structural remodeling and predictor of transition from paroxysmal to chronic form. Int J Cardiol. 2011;148:139–47.
Behnes M, Akin I, Sartorius B, et al. –LAA Occluder View for post-implantation Evaluation (LOVE)–standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography. BMC Med Imaging. 2016;16:25.
Kaafarani M, Saw J, Daniels M, et al. Role of CT imaging in left atrial appendage occlusion for the WATCHMAN™ device. Cardiovasc Diagn Ther. 2020;10:45–58.
Qamar SR, Jalal S, Nicolaou S, Tsang M, Gilhofer T, Saw J. Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure. EuroIntervention. 2019;15:663–70.
Saw J, Fahmy P, DeJong P, et al. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. Eur Heart J Cardiovasc Imaging. 2015;16:1198–206.
Dukkipati SR, Kar S, Holmes DR, et al. Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes. Circulation. 2018;138:874–85.
Fauchier L, Cinaud A, Brigadeau F, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71:1528–36.
Simard T, Jung RG, Lehenbauer K, et al. Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol. 2021;78:297–313.
Sedaghat A, Vij V, Al-Kassou B, et al. Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry. Circ Cardiovasc Interv. 2021;14:e010195.
Banga S, Osman M, Sengupta PP, et al. CT assessment of the left atrial appendage post-transcatheter occlusion—a systematic review and meta analysis. J Cardiovasc Comput Tomogr. 2021;15:348–55.
Zhao MZ, Chi RM, Yu Y, et al. Value of detecting peri-device leak and incomplete endothelialization by cardiac CT angiography in atrial fibrillation patients post Watchman LAAC combined with radiofrequency ablation. J Cardiovasc Electrophysiol. 2021;32:2655–64.
Korsholm K, Jensen JM, Nielsen-Kudsk JE. Cardiac computed tomography for left atrial appendage occlusion: acquisition, analysis, advantages, and limitations. Interv Cardiol Clin. 2018;7:229–42.
Yamamoto M, Adachi Y, Tsunaki T, Suzuki T. Newly developed collateral artery inside a left appendage closure device. JACC Cardiovasc Interv. 2021;14:2744–5.
Murtaza G, Murtaza KT, Dar T, et al. Left atrial appendage occlusion device embolization (the Laaode study): understanding the timing and clinical consequences from a worldwide experience. J Atr Fibrillation. 2021;13:2516.
Acknowledgements
The author thanks Naoki Hosoda for his valuable contributions for providing excellent figures.
Funding
This research received no grant from any funding agency in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
Dr. Asami is a clinical proctor for Boston Scientific and has received remuneration from Boston Scientific, Abbott Medical, Edwards Lifesciences, Medtronic, Canon Medical Systems, and Ziosoft.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Asami, M., the OCEAN-SHD Investigators. Computed tomography measurement for left atrial appendage closure. Cardiovasc Interv and Ther 37, 440–449 (2022). https://doi.org/10.1007/s12928-022-00852-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12928-022-00852-4